These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3431962)

  • 41. Chlorpromazine and liver function; the effect of prolonged oral administration.
    DUNDEE JW
    Anaesthesia; 1957 Apr; 12(2):215-22. PubMed ID: 13424991
    [No Abstract]   [Full Text] [Related]  

  • 42. [Action of chlorpromazine on heart rate and tonicity of cardio-accelerator centers].
    DUCHENE-MARULLAZ P; JOURDAN F
    Arch Int Pharmacodyn Ther; 1956 Sep; 107(3-4):304-14. PubMed ID: 13363503
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of chlorpromazine upon experimental hepatic injury.
    POPPER H; DUBIN A; BRUCE C; KENT G; KUSHNER D
    J Lab Clin Med; 1957 May; 49(5):767-73. PubMed ID: 13416737
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of chlorpromazine on hepatic function and morphology.
    DAUGHERTY C; DEVORE JK; SCHNEIDER EM
    Gastroenterology; 1956 Oct; 31(4):391-8. PubMed ID: 13365846
    [No Abstract]   [Full Text] [Related]  

  • 45. [Experimental studies of the effect of megaphen on the liver].
    KRETZSCHMAR E; SCHOLZ O
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1956; 283(5):515-27. PubMed ID: 13399209
    [No Abstract]   [Full Text] [Related]  

  • 46. Influence of drugs on pyrogene reactions; practical testing of injection solutions with pyrogene substances.
    FREY HH; HOLTZ G; SOEHRING K
    Arch Pharm Ber Dtsch Pharm Ges; 1956 Jan; 289(1):29-32. PubMed ID: 13328047
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of chlorpromazine on the isolated heart during hypothermia].
    AREZIO G; METALLI P; SILINI G
    Minerva Cardioangiol; 1957 Aug; 5(8):309-13. PubMed ID: 13503726
    [No Abstract]   [Full Text] [Related]  

  • 48. [The liver-damaging action of chlorpromazine].
    NORREDAM K
    Ugeskr Laeger; 1962 Sep; 124():1351-63. PubMed ID: 13938957
    [No Abstract]   [Full Text] [Related]  

  • 49. MLN4924 Treatment Diminishes Excessive Lipid Storage in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease (NAFLD) by Stimulating Hepatic Mitochondrial Fatty Acid Oxidation and Lipid Metabolites.
    Ge M; Huang L; Ma Y; Sun S; Wu L; Xu W; Yang D
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mitochondrial, but not peroxisomal, beta-oxidation of fatty acids is conserved in coenzyme A-deficient rat liver.
    Youssef JA; Song WO; Badr MZ
    Mol Cell Biochem; 1997 Oct; 175(1-2):37-42. PubMed ID: 9350031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders.
    Infante JP; Huszagh VA
    Mol Cell Biochem; 1997 Mar; 168(1-2):101-15. PubMed ID: 9062899
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Secondary alterations of human hepatocellular peroxisomes.
    De Craemer D
    J Inherit Metab Dis; 1995; 18 Suppl 1():181-213. PubMed ID: 9053551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic peroxisomes in adrenoleukodystrophy and related syndromes: cytochemical and morphometric data.
    Roels F; Pauwels M; Poll-Thé BT; Scotto J; Ogier H; Aubourg P; Saudubray JM
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(4):275-85. PubMed ID: 3140473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liver pathology and immunocytochemistry in congenital peroxisomal diseases: a review.
    Roels F; Espeel M; De Craemer D
    J Inherit Metab Dis; 1991; 14(6):853-75. PubMed ID: 1779645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peroxisomal proliferation in heart and liver of mice receiving chlorpromazine, ethyl 2(5(4-chlorophenyl)pentyl) oxiran-2-carboxylic acid or high fat diet: a biochemical and morphometrical comparative study.
    Vamecq J; Roels F; Van den Branden C; Draye JP
    Pediatr Res; 1987 Dec; 22(6):748-54. PubMed ID: 3431962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chlorpromazine and carnitine-dependency of rat liver peroxisomal beta-oxidation of long-chain fatty acids.
    Vamecq J
    Biochem J; 1987 Feb; 241(3):783-91. PubMed ID: 3593222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peroxisomal fatty acid oxidation and inhibitors of the mitochondrial carnitine palmitoyltransferase I in isolated rat hepatocytes.
    Skorin C; Necochea C; Johow V; Soto U; Grau AM; Bremer J; Leighton F
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):561-7. PubMed ID: 1736904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Co-ordinate induction of hepatic mitochondrial and peroxisomal carnitine acyltransferase synthesis by diet and drugs.
    Brady PS; Marine KA; Brady LJ; Ramsay RR
    Biochem J; 1989 May; 260(1):93-100. PubMed ID: 2775196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver peroxisomal fatty acid oxidizing system during aging in control and clofibrate-treated mice.
    Périchon R; Bourre JM
    Biochem Mol Biol Int; 1995 Oct; 37(3):475-80. PubMed ID: 8595387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of various n-3/n-6 fatty acid ratio contents of high fat diets on rat liver and heart peroxisomal and mitochondrial beta-oxidation.
    Vamecq J; Vallee L; de la Porte PL; Fontaine M; de Craemer D; van den Branden C; Lafont H; Grataroli R; Nalbone G
    Biochim Biophys Acta; 1993 Oct; 1170(2):151-6. PubMed ID: 8399339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.